Healthy volunteers test diabetes Drug's body behavior
NCT ID NCT07056517
First seen May 02, 2026 · Last updated May 02, 2026
Summary
This study tested a diabetes drug called lobeglitazone in 21 healthy adults to see how it moves through the body when taken as a new melt-in-the-mouth tablet (M107 ODT) compared to the standard Duvie tablet. Participants took a single dose under both fasting and fed conditions. The goal was to measure drug levels and safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Pty Ltd.
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.